Immunohistochemical Assessment of an Asymptomatic Glucagonoma in a Patient With Hypergastrinemia and Marked Antral Angiodysplasia

Weitgasser, Raimund; Sungler, P.; Hauser‐Kronberger, Cornelia; Dietze, Otto; Sattlegger, Peter; Hacker, Gerhard W.

doi:10.1097/00129039-200103000-00017

Cited by 4 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Frequently, GAVE is associated with chronic liver disease and autoimmune or connective tissue diseases, like primary biliary cirrhosis, hypothyroidism, progressive systemic sclerosis, Raynaud's phenomenon, sclerodactyly, atrophic body gastritis and pernicious anemia (7) . Association with other diseases like coronary disease, chronic renal failure, diabetes, chronic obstructive pulmonary disease, parkinsonism (7) , lymphoma (16) , glucagonoma (23) and bone marrow transplant (21) were also reported.…”

Section: Resultsmentioning

confidence: 93%

Watermelon stomach: clinical aspects and treatment with argon plasma coagulation

Chaves

Sakai

Oliveira

et al. 2006

Arq. Gastroenterol.

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 93%

Watermelon stomach: clinical aspects and treatment with argon plasma coagulation

Chaves

Sakai

Oliveira

et al. 2006

Arq. Gastroenterol.

View full text Add to dashboard Cite

show abstract

“…Octreotide was also used successfully in a patient with glucagonoma and marked antral vascular ectasia. 51 Another case of gastric antral vascular ectasia in a non-cirrhotic patient failed to show a response to octreotide. 52 It is probable that the reduction in portal pressure by octreotide may account for the benefit seen in gastric antral vascular ectasia associated with cirrhosis.…”

Section: Medical Treatmentmentioning

confidence: 99%

“…All patients also had endoscopic therapy. Octreotide was also used successfully in a patient with glucagonoma and marked antral vascular ectasia 51 . Another case of gastric antral vascular ectasia in a non‐cirrhotic patient failed to show a response to octreotide 52 .…”

mentioning

confidence: 99%

Current therapeutic options for gastric antral vascular ectasia

Sebastian

O’Moráin

Buckley

2003

Aliment Pharmacol Ther

115

105

View full text Add to dashboard Cite

Summary Gastric antral vascular ectasia, or ‘watermelon stomach’, is a rare but important cause of gastrointestinal blood loss and anaemia, which has characteristic endoscopic and histological features. The pathogenesis of this condition remains unclear; however, many associated disorders have been documented. Various medical, surgical and endoscopic therapeutic modalities have been attempted with variable success. Leading contenders for the therapeutic modality of choice include hormonal therapy, endoscopic Nd:YAG laser and argon plasma coagulation. Randomized controlled trials to identify the ideal treatment method are lacking at present.

show abstract

Radiofrequency Ablation for Treatment of Refractory Gastric Antral Vascular Ectasia: A Systematic Review of the Literature

Maida¹,

Camilleri²,

Manganaro³

et al. 2017

Gastroenterology Research and Practice

View full text Add to dashboard Cite

Background and Study Aims GAVE is an uncommon cause of upper nonvariceal bleeding and often manifests itself as occult bleeding with chronic anemia. To date, the standard of care for GAVE is endoscopic treatment with thermoablative techniques. Despite good technical results, approximately two thirds of patients remain dependent on transfusions after the therapy. One of the emerging and more promising endoscopic treatments for GAVE is radiofrequency ablation (RFA). The aim of this study is to perform a systematic review of literature in order to assess current evidence supporting the effectiveness of this technique for treatment of refractory GAVE. Materials and Methods Through electronic search, we identified 14 records, and after removal of duplicates and irrelevant studies, we selected 10 studies on radiofrequency ablation of GAVE: 4 prospective open-label single-center studies, 1 retrospective multicentric study, and 5 case reports. Results Among all 72 treated patients reported in literature, 74.3% achieved a clinical response, while nonfatal AEs have been reported in 4.2% of cases. Conclusions Despite some qualitative limitations, all literature data support effectiveness of RFA for treatment of refractory GAVE. In the future, large prospective controlled trials with adequate follow-up are needed to better assess the effectiveness and safety of this procedure.

show abstract

Immunohistochemical Assessment of an Asymptomatic Glucagonoma in a Patient With Hypergastrinemia and Marked Antral Angiodysplasia

Cited by 4 publications

References 11 publications

Watermelon stomach: clinical aspects and treatment with argon plasma coagulation

Watermelon stomach: clinical aspects and treatment with argon plasma coagulation

Current therapeutic options for gastric antral vascular ectasia

Radiofrequency Ablation for Treatment of Refractory Gastric Antral Vascular Ectasia: A Systematic Review of the Literature

Contact Info

Product

Resources

About